Paradoxical expression of E-cadherin in prostatic bone metastases

BJU International

Volumn 84, Issue 9, 1999, Pages 1032-1034

  Bryden, A A G ^a   Freemont, A J ^b   Clarke, N W ^c   George, N J R ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bone metastases; E cadherin; Prostate cancer

Indexed keywords

CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; UVOMORULIN;

ARTICLE; BONE BIOPSY; BONE METASTASIS; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

BIOPSY; BONE NEOPLASMS; CADHERINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS;

EID: 0032757728     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00378.x     Document Type: Article

References (14)

1. 1 Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5
2. 2 Näthke I, Hinck L, Swedlow JR, Papkoff J, Nelson WJ. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol 1994; 125: 1341-52
3. 3 Frixen U, Behrens J, Sachs M et al. E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85
4. 4 Bussemakers M, van Moorselaar RJA, Giroldi LA et al. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 1992; 52: 2916-22
5. 5 Umbas R, Schalken JA, Aalders TW et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 1992; 52: 5104-9
6. 6 Umbas R, Isaacs WB, Bringuier PP et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994; 54: 3929-33
7. 7 Tamura M. The E-cadherin-mediated cell-cell adhesion system in human cancers. Br J Surg 1997; 84: 899-900
8. 8 Schipper J, Unger A, Jahnke K. E-cadherin as a functional marker for the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin Otolaryngol 1994; 49: 381-4
9. 9 Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TC. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 1996; 148: 1375-80
10. 10 McWilliam L, Knox WF, Hills C, George NJR. E-cadherin expression fails to predict progression and survival in prostate cancer. J Urol 1996; 155: 516
11. 11 Marcel M, Behrens J, Birchmeier W et al. Down regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 1991; 47: 922-8
12. 12 Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T. E-cadherin expression in upper urinary-tract carcinoma. Int J Cancer 1997; 74: 446-9
13. 13 Ligtenberg M, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992; 52: 2318-24
14. 14 Shimoyama Y, Nagafuchi A, Fujita S et al. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992; 52: 5770-4